TSPAN19 (TSN19_HUMAN) as a Drug Target and Biomarker (G144448)

Target Name: TSPAN19

NCBI ID: G144448

TSPAN19

TSPAN19 (TSN19_HUMAN) as a Drug Target and Biomarker

Abstract: TSPAN19 (T-Spanin-19), a sphingomyelin synthase gene, has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. This article reviews the current research on TSPAN19, including its function, potential drug targets, and potential as a biomarker for disease diagnosis and treatment.

Introduction:

Sphingomyelin synthase (SMAS) is a transmembrane protein that plays a crucial role in the synthesis of sphingomyelin, a major component of cell membranes. The SMAS gene has four splice variants, including TSPAN19 (T-Spanin-19), which has been identified as a potential drug target and biomarker for various diseases.

Function of TSPAN19:

TSPAN19 is a 21-kDa protein that is expressed in various tissues and organs, including brain, heart, skeletal muscles, and pancreatic beta cells. It is involved in the synthesis of sphingomyelin and has been shown to play a role in the regulation of intracellular signaling pathways, including the cAMP/cGMP signaling pathway, which is involved in inflammation, stress, and cellular signaling.

Potential Drug Targets:

TSPAN19 has been identified as a potential drug target for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

1. Neurodegenerative Disorders:

TSPAN19 has been shown to be involved in the development and progression of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Studies have shown that TSPAN19 levels are decreased in the brains of individuals with these disorders, and that inhibiting TSPAN19 activity can lead to improved cognitive function and reduced neurodegeneration.

2. Cancer:

TSPAN19 has also been identified as a potential drug target for cancer. Several studies have shown that TSPAN19 is involved in the regulation of cell proliferation and has been shown to promote the growth of cancer cells. inhibiting TSPAN19 activity has been shown to be an effective way to inhibit the growth of cancer cells.

3. Autoimmune Diseases:

TSPAN19 has also been shown to be involved in the development and regulation of autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis. Studies have shown that TSPAN19 is involved in the regulation of T cell development and that inhibiting TSPAN19 activity can be an effective way to treat autoimmune diseases.

Potential as a Biomarker:

TSPAN19 has also been shown to be potential biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

1. Neurodegenerative Disorders:

TSPAN19 has been shown to be involved in the regulation of neurotransmitter synthesis and has been shown to play a role in the development and progression of neurodegenerative disorders. Studies have shown that TSPAN19 levels are decreased in the brains of individuals with Alzheimer's disease and that inhibiting TSPAN19 activity can lead to improved cognitive function and reduced neurodegeneration.

2. Cancer:

TSPAN19 has also been shown to be involved in the regulation of cell proliferation and has been shown to promote the growth of cancer cells. inhibiting TSPAN19 activity has been shown to be an effective way to inhibit the growth of cancer cells.

3. Autoimmune Diseases:

TSPAN19 has also been shown to be involved in the regulation of T cell development and that inhibiting TSPAN19 activity can be an effective way to treat autoimmune diseases.

Conclusion:

TSPAN19 is a protein that has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Further research is needed to fully understand the role of TSPAN19 in these diseases and to develop effective treatments. inhibiting TSPAN19 activity has been shown to be an effective way to treat these diseases, and further research is needed to

Protein Name: Tetraspanin 19

The "TSPAN19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSPAN19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets